Gary C. Burgess - Net Worth and Insider Trading
Gary C. Burgess Net Worth
The estimated net worth of Gary C. Burgess is at least $67,879 dollars as of 2024-11-10. Gary C. Burgess is the Sr. VP, Clin. Res. & CMO of Conatus Pharmaceuticals Inc and owns about 121,212 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $67,879. Details can be seen in Gary C. Burgess's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gary C. Burgess has not made any transactions after 2013-07-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gary C. Burgess
Gary C. Burgess Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gary C. Burgess owns 1 companies in total, including Histogen Inc (HSTO) .
Click here to see the complete history of Gary C. Burgess’s form 4 insider trades.
Insider Ownership Summary of Gary C. Burgess
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HSTO | Histogen Inc | 2013-07-24 | Sr. VP & Clin. Res. & CMO |
Gary C. Burgess Latest Holdings Summary
Gary C. Burgess currently owns a total of 1 stock. Gary C. Burgess owns 121,212 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 24, 2013, with a value of $67,879.
Latest Holdings of Gary C. Burgess
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNAT | Conatus Pharmaceuticals Inc | 2013-07-24 | 121,212 | 0.56 | 67,879 |
Holding Weightings of Gary C. Burgess
Gary C. Burgess Form 4 Trading Tracker
According to the SEC Form 4 filings, Gary C. Burgess has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the sale of 0 shares on July 24, 2013, which brought Gary C. Burgess around $0.
Insider Trading History of Gary C. Burgess
- 1
Gary C. Burgess Trading Performance
Gary C. Burgess Ownership Network
Ownership Network List of Gary C. Burgess
Ownership Network Relation of Gary C. Burgess
Gary C. Burgess Owned Company Details
What does Histogen Inc do?
Who are the key executives at Histogen Inc?
Gary C. Burgess is the Sr. VP & Clin. Res. & CMO of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .
Histogen Inc (HSTO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Histogen Inc (HSTO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Histogen Inc Insider Transactions
Gary C. Burgess Mailing Address
Above is the net worth, insider trading, and ownership report for Gary C. Burgess. You might contact Gary C. Burgess via mailing address: C/o Conatus Pharmaceuticals Inc., 4365 Executive Drive, Suite 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
